101 – 120 of 214
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Short-Term Diabetes Blood Glucose Prediction Based On Blood Glucose Measurements
2009) 2nd Int. Conference on Advanced Technologies and Treatments for Diabetes 2009(
- Contribution to conference › Paper, not in proceeding
-
Mark
Subspace-Based Model Identification of Diabetic Blood Glucose Dynamics
(
- Contribution to journal › Article
- 2008
-
Mark
Risk Conferred by HLA-DR and DQ for Type 1 Diabetes in 0-35-Year Age Group in Sweden
2008) 9th International Congress of the Immunology-of-Diabeties-Society/American-Diabeties-Association-Research Symposium 1150. p.106-111(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta-cell autoimmunity and individuals with lesser or no beta-cell autoimmunity
(
- Contribution to journal › Article
-
Mark
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Pregnancies in prediabetic women
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.467-468(
- Contribution to journal › Published meeting abstract
-
Mark
Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.
(
- Contribution to journal › Article
-
Mark
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
(
- Contribution to journal › Article
-
Mark
Effects of the DPP-4 Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects with Impaired Glucose Tolerance
(
- Contribution to journal › Article
-
Mark
Common variants in or around the JAZF1, CDKN2A/2B, CDKAL1 and WFS1 genes discriminate between autoimmune and non-autoimmune diabetes
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.117-117(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term consequences on annual earnings of the onset of type I diabetes in young adults. Longitudinal analysis of annual data 1990-2005 for persons born 1949-1970
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.443-443(
- Contribution to journal › Published meeting abstract
-
Mark
Early insulin treatment in latent autoimmune diabetes in adults (LADA) did not improve residual beta cell function or metabolic control
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.391-391(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Determination of glutamic acid decarboxylase antibodies (GADA) IgG subclasses - comparison of three immunoprecipitation assays (IPAs)
(
- Contribution to journal › Article
-
Mark
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
(
- Contribution to journal › Article
-
Mark
Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
(
- Contribution to journal › Article
-
Mark
Presence of GAD-antibodies during gestational diabetes predicts type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
No evidence of association of the PDCD1 gene with Type 1 diabetes
(
- Contribution to journal › Article
-
Mark
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients
(
- Contribution to journal › Article
- 2006
-
Mark
MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: A randomised open-label parallel group four months comparison in patients with type 2 diabetes
(
- Contribution to journal › Article